Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Non-cash Items (2016 - 2019)

VYNE Therapeutics (VYNE) has disclosed Non-cash Items for 4 consecutive years, with $2.9 million as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Non-cash Items rose 14.27% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Dec 2019, up 14.27%, and an annual FY2019 reading of $2.9 million, up 14.27% over the prior year.
  • Non-cash Items was $2.9 million for Q4 2019 at VYNE Therapeutics, up from $2.8 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $24.0 million in Q4 2017 and bottomed at $2.5 million in Q4 2018.
  • Average Non-cash Items over 4 years is $8.7 million, with a median of $5.7 million recorded in 2019.
  • The sharpest move saw Non-cash Items surged 531.62% in 2017, then tumbled 89.56% in 2018.
  • Year by year, Non-cash Items stood at $3.8 million in 2016, then soared by 531.62% to $24.0 million in 2017, then crashed by 89.56% to $2.5 million in 2018, then rose by 14.27% to $2.9 million in 2019.
  • Business Quant data shows Non-cash Items for VYNE at $2.9 million in Q4 2019, $2.8 million in Q3 2019, and $5.7 million in Q2 2019.